0.785
0.79 (-2.08%)
As of Mar 06, 2024
Hookipa Pharma Inc. [HOOK]
Source:
Company Overview
We are a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on our proprietary arenavirus platform that is designed to target and amplify a T cell and immune response to disease. Our replicating and non-replicating technologies are engineered to induce robust and durable antigen-specific CD8 T cell responses and pathogen-neutralizing antibodies.
Country | United States |
Headquarters | new york, new york |
Phone Number | 0114318906360 |
Industry | manufacturing |
CEO | Joern Aldag |
Website | www.hookipapharma.com |